Back to Agenda
Session 5: Divergences, Harmonization, and Patient Perspective in Risk Minimization
Session Chair(s)
Michael Richardson, MD, FFPM, FRCP
Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
Presenters will discuss the challenges and opportunities implementing risk minimization measures globally, including challenges associated with harmonizing global implementation of risk minimization. Additionally, the patient experience will be considered and behavioral science approaches described which place risk and risk minimization in meaningful context for patients, healthcare providers, and creators of minimization measures and risk messages.
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe challenges to establishing global approaches to risk minimization
- Identify risk analysis approaches to developing risk minimization materials
- Recognize how regulatory differences impact global risk management organizations and design/implementation of risk minimization materials
Speaker(s)
Using Related Risk Analysis in Risk Minimization Measure Design and Implications for Globally Harmonized Approaches
James Duhig, PhD
AbbVie, United States
Global Head, Office of Health Literacy
Speakers
Lacey Leigh Lucree, MPH
Truliant Consulting, United States
Co-Founder and Partner
Speaker
Jamie Wilkins, PharmD
Pfizer Inc, United States
Head- Risk Management Center of Excellence
Have an account?